Peer Review reports
From: Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
| Original Submission | ||
|---|---|---|
| 15 Dec 2020 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| 14 Feb 2021 | Reviewed | Reviewer Report |
| 16 Feb 2021 | Reviewed | Reviewer Report |
| 1 Mar 2021 | Reviewed | Reviewer Report |
| 22 Mar 2021 | Author responded | Author comments - Wilhelm Aicher |
| Resubmission - Version 6 | ||
| 22 Mar 2021 | Submitted | Manuscript version 6 |
| 29 Mar 2021 | Reviewed | Reviewer Report |
| 30 Mar 2021 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 1 Apr 2021 | Editorially accepted | |
| 12 Apr 2021 | Article published | 10.1186/s12894-021-00829-0 |
You can find further information about peer review here.